Literature DB >> 8622047

When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood.

C Elliott1, D M Samson, S Armitage, M P Lyttelton, D McGuigan, R Hargreaves, C Giles, G Abrahamson, Z Abboudi, M Brennan, E J Kanfer.   

Abstract

PURPOSE: To evaluate whether the CD34+ yield from a single peripheral-blood stem-cell (PBSC) harvest could be predicted by measurement of the patient's circulating WBC and CD34+ cell concentrations on the day before harvest. PATIENTS AND METHODS: Thirty-nine patients with hematologic or nonhematologic malignancy underwent 41 stem-cell mobilization episodes with cytotoxic chemotherapy and/or granulocyte colony-stimulating factor (G-CSF), and a total of 63 leukapheresis procedures were performed. Peripheral-blood samples were analyzed for WBC and CD34+ cell concentration both on the day before and the day of leukapheresis.
RESULTS: The median WBC and CD34+ concentrations on the day preceding leukapheresis were 10.0 x 10(9)/L (range, 0.4 to 44.4) and 24.9 x 10(6)/L (range, 0.1 to 349.4), respectively. On the day of harvest, the corresponding figures were 15.1 x 10(9)/L (range, 1.5 to 52.6) and 29.3 x 10(6)/L (range, 0.1 to 543.1), respectively. The median CD34+ cell number collected in a single leukapheresis was 2.6 x 10(6)/kg body weight (range, 0.1 to 26.1). Both the preceding day (r = .84, P < .001) and harvest day (r = .95, P < .001) CD34+ circulating concentrations correlated significantly with the number of CD34+ cells per kilogram collected at leukapheresis. The correlation between CD34+ cells per kilogram collected and harvest day WBC count was also significant (r = .43, P <.001), but with the preceding day WBC count was nonsignificant.
CONCLUSION: The number of CD34+ cells harvested in a single leukapheresis can be predicted by measurement of the preceding day peripheral-blood circulating CD34+ concentration, and on the basis of these data a table of probable CD34+ cell yield has been constructed. This correlation may facilitate the efficient organization of leukapheresis procedures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622047     DOI: 10.1200/JCO.1996.14.3.970

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  13 in total

Review 1.  Supportive care in patients with acute leukaemia: historical perspectives.

Authors:  Giovanna Cannas; Xavier Thomas
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

2.  Assessment of haematopoietic progenitor cell counting with the Sysmex® XN-1000 to guide timing of apheresis of peripheral blood stem cells.

Authors:  Francesco Dima; Erika Barison; Martina Midolo; Fabio Benedetti; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2019-07-25       Impact factor: 3.443

3.  Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections.

Authors:  Ellinor I Peerschke; Christine Moung; Melissa S Pessin; Peter Maslak
Journal:  Transfusion       Date:  2015-03-21       Impact factor: 3.157

4.  Prediction model for CD34 positive cell yield in peripheral blood stem cell collection on the fourth day after G-CSF administration in healthy donors.

Authors:  Tetsuichi Yoshizato; Naoko Watanabe-Okochi; Yasuhito Nannya; Motoshi Ichikawa; Tsuyoshi Takahashi; Tomohiko Sato; Akiko Masuda; Yutaka Yatomi; Nelson Hirokazu Tsuno; Mineo Kurokawa; Koki Takahashi
Journal:  Int J Hematol       Date:  2013-05-22       Impact factor: 2.490

5.  Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.

Authors:  Abba C Zubair; Rhonda Grant; Wenting Wu; Han Tun; Candido Rivera; Alvaro Moreno-Aspitia; Michael Joyce; Vivek Roy; Gerardo Colon-Otero; Lawrence A Solberg
Journal:  Transfusion       Date:  2008-02-25       Impact factor: 3.157

6.  Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo.

Authors:  A Olivieri; M Marchetti; R Lemoli; C Tarella; A Iacone; F Lanza; A Rambaldi; A Bosi
Journal:  Bone Marrow Transplant       Date:  2011-05-30       Impact factor: 5.483

7.  A simplified CD34+ based preharvest prediction tool for HPC(A) collection.

Authors:  Reuben P Jacob; Scott T Avecilla; Eileen M Walsh; Peter G Maslak; Sergio A Giralt
Journal:  Transfusion       Date:  2021-03-11       Impact factor: 3.337

8.  The new Sysmex XN-2000 automated blood cell analyzer more accurately measures the absolute number and the proportion of hematopoietic stem and progenitor cells than XE-2100 when compared to flow cytometric enumeration of CD34+ cells.

Authors:  Sang Hyuk Park; Chan-Jeoung Park; Mi-Jeong Kim; Min-Young Han; Sang-Hee Han; Young-Uk Cho; Seongsoo Jang
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

9.  Algorithms utilizing peripheral blood hematopoietic progenitor cell counts in lieu of some CD34+ cell counts predict successful peripheral blood stem cell collections with substantial time and cost savings.

Authors:  B W Steussy; M Capper; M D Krasowski; N S Rosenthal; A J Schlueter
Journal:  ISBT Sci Ser       Date:  2016-10-05

10.  High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels.

Authors:  E J Kanfer; D McGuigan; D Samson; Z Abboudi; G Abrahamson; J F Apperley; S Chilcott; C Craddock; J Davis; C MacDonald; D Macdonald; E Olavarria; N Philpott; G J Rustin; M J Seckl; M Sekhar; S Stern; E S Newlands
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.